
The dispute could force Edwards to pay a substantial sum and set a legal benchmark for earn‑out enforcement in the life‑sciences sector, influencing future acquisition structuring and investor risk assessments.
Earn‑out clauses have become a staple in high‑value healthcare acquisitions, allowing sellers to receive additional compensation if post‑deal milestones are met. Edwards Lifesciences’ 2016 purchase of Valtech Cardio included a $300 million earn‑out tied to the commercial launch of a next‑generation heart‑valve repair system. While such structures align incentives, they also create litigation risk when parties disagree on performance metrics or development timelines. The current suit alleges Edwards intentionally slowed the product’s progress, a claim that, if proven, could expose the company to significant financial exposure and reshape how earn‑outs are negotiated in the sector.
The Delaware Court of Chancery, renowned for its expertise in corporate disputes, will adjudicate the case, applying its well‑developed body of case law on fiduciary duties and contract enforcement. A ruling favoring the plaintiffs could establish a precedent that discourages acquirers from manipulating development schedules to evade earn‑out payments. Conversely, a dismissal may reinforce the latitude companies have in managing R&D pipelines post‑acquisition. Legal analysts are watching closely, as the outcome may reverberate through private‑equity‑backed deals and biotech mergers where milestone‑based compensation is common.
Beyond the courtroom, the lawsuit sends a cautionary signal to investors and boardrooms. A sizable judgment against Edwards could dent its earnings outlook, affect its stock price, and prompt tighter covenant structures in future deals. Companies may respond by tightening earn‑out definitions, incorporating clearer performance metrics, or opting for cash‑only consideration to mitigate litigation risk. For stakeholders across the medical‑device ecosystem, the case underscores the importance of transparent integration plans and robust governance to safeguard both shareholder value and product innovation.
Edwards Sued In Chancery Over $300M Heart Valve Earn-Out - Law360
Try our [Advanced Search] for more refined results
|
[Access to Justice] [Aerospace & Defense] [Appellate] [Asset Management] [Banking] [Bankruptcy] [Benefits] [California] [Cannabis] [Capital Markets] [Class Action] [Colorado] [Commercial Contracts] [Competition] [Compliance] [Connecticut] [Construction] [Consumer Protection] [Corporate] [Criminal Practice] [Cybersecurity & Privacy] [Delaware] [Employment]
[Energy] [Environmental] [Fintech] [Florida] [Food & Beverage] [Georgia] [Government Contracts] [Health] [Hospitality] [Illinois] [Immigration] [Insurance] [Intellectual Property] [International Arbitration] [International Trade] [Legal Ethics] [Legal Industry] [Life Sciences] [Massachusetts] [Media & Entertainment] [Mergers & Acquisitions] [Michigan] [Native American]
[New Jersey] [New York] [North Carolina] [Ohio] [Pennsylvania] [Personal Injury & Medical Malpractice] [Private Equity] [Product Liability] [Project Finance] [Public Policy] [Real Estate] [Retail & E-Commerce] [Securities] [Sports & Betting] [Tax] [Technology] [Telecommunications] [Texas] [Transportation] [Trials] [Washington] [White Collar]
|
[California Pulse] [Connecticut Pulse] [Courts] [DC Pulse] [Daily Litigation] [Delaware Pulse]
[Florida Pulse] [Georgia Pulse] [In-House] [Insights] [Legal Tech & AI] [Mid-Law]
[Modern Lawyer] [New Jersey Pulse] [New York Pulse] [Pennsylvania Pulse] [Small Law] [Texas Pulse]
|
[Federal] [International] [State & Local]
[Discrimination] [Labor] [Other] [Wage & Hour]
[General Liability] [Other] [Property] [Specialty Lines]
[Commercial] [Other] [Residential]
[Large Cap] [Mid Cap]
[Deals & Corporate Governance] [Digital Health & Technology] [Other] [Policy & Compliance]
[Commercial Litigation UK] [Corporate Crime & Compliance UK] [Employment UK] [Financial Services UK] [Insurance UK] [Intellectual Property UK] [Pulse UK] [Transactions UK]
Close
[Law360 Bankruptcy Authority]
[Law360 Healthcare Authority]
[Law360 Real Estate Authority]
[Law360 Insurance Authority]
[Law360 Tax Authority]
[Law360 Employment Authority]
[Law360 Pulse]
[Law360 UK]
Law360
[Law360 Podcasts]
[Law360 In-Depth]
[Lexis®]
Products
[Titans of the Plaintiffs Bar]
[Rising Stars]
[Practice Groups of the Year]
[Diversity Snapshot]
[Law360 400]
[Women in Law Report]
[Law360's MVPs]
[Regional Powerhouses]
[Leaderboard Analytics]
Rankings
[Securities]
[Product Liability]
[Intellectual Property]
[Insurance]
[Expert Analysis]
[Energy]
[Employment]
[Competition]
[Class Action]
[Bankruptcy]
[Banking]
[Browse all sections]
[About all sections]
[Adv. Search & Platform Tools]
Sections
[Track judges]
[Track attorneys]
[Track docs]
Beta Tools
[Help]
[Site Map]
[Resource Library]
[About Law360 Authority]
[Law360 Company]
[Sign up for our newsletters]
[Contact Law360]
[Read testimonials]
[Learn more about Law360]
[Search legal jobs]
[Join the Law360 team]
Site Menu
[CaseMap®] [CLE On-Demand] [Context] [CourtLink®] [Digital Library] [Intelligize] [Law360] [Lex Machina] [Lexis Medical Navigator™] [Lexis®] [Lexis+™]
[Lexis® Tax] [MLex®] [Nexis®] [Nexis Diligence™] [Nexis Newsdesk™] [Practical Guidance] [Product Liability Navigator] [Securities Mosaic®] [State Net®] [Verdict & Settlement Analyzer]
By Jarek Rutz ( February 17, 2026, 2:20 PM EST) -- The former shareholders of Valtech Cardio Ltd. have sued the company and its parent Edwards Lifesciences Corp. in the Delaware Chancery Court, accusing the medical device giant of deliberately stalling development of a heart valve repair system to avoid paying up to $300 million in earn-out consideration tied to the 2016 acquisition....
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
450K+ searchable archived articles
Real-time alerts
Judge information
Advanced search
Mobile app
Expert analysis
Daily newsletters
And more!
Experience Law360 today with a free 7-day trial.
[Technology]
[Mergers & Acquisitions]
[Life Sciences]
[Health]
[Delaware]
[Commercial Contracts]
[Subscribers Only]
[Subscribers Only]
[Subscribers Only]
[Subscribers Only]
[Subscribers Only]
[Subscribers Only]
[Food and Drug Administration]
[European Union]
[Delaware Court of Chancery]
Comments
Want to join the conversation?
Loading comments...